Patrick Kwak

PATRICK KWAK advises clients on international corporate finance transactions and securities regulation.

He draws on a sophisticated understanding of the market and deep technical knowledge to represent private equity sponsors, their portfolio company, and corporate issuers in:

• Public and private debt securities offerings, including Rule 144A offerings, with an emphasis on high-yield debt products;
• Leveraged and acquisition financing, including bridge financing;
• Private credit financings;
• Holdco financings; and
• Restructurings and liability management transactions, including tender offers, consent solicitations, and exchange offers.

Chambers UK 2026 ranks Patrick as “Up and Coming” for Capital Markets: High-Yield Products, where a client state “he really got into the weeds with me on complex documents. He was great at understanding all the details of the document and what our commercial goals were.” Patrick is also recognized in the Legal 500 UK 2026 as a “Next Generation Partner” for Finance: High Yield. In the Legal 500 UK 2023, he was described as “highly regarded by the market.”

Recent examples of Patrick’s work include advising:

• Adevinta, a leading European online classifieds group backed by a consortium of shareholders including Blackstone and Permira, on financing arrangements to refinance its existing debt facilities and facilitate a distribution to shareholders.
• ADVANZ PHARMA, a Nordic Capital portfolio company, in connection with the issuance of €917 million (equivalent) in new euro- and pound sterling-denominated senior secured notes and the borrowing of a €165 million term loan B facility.
• Clearlake Capital in its US$7.7 billion take-private acquisition of Dun & Bradstreet, a global provider of business decisioning data and analytics.
• Belron UK Finance plc on its €4.2 billion (equivalent) senior secured note and term loan financing, the proceeds of which were used to pay an extraordinary dividend to its shareholders.
• Permira and Blackstone-led consortium on the private credit loan financing for the €14 billion voluntary tender offer to acquire all of the outstanding ordinary shares in Adevinta ASA.
• EQT and Limacorporate on the refinancing of its existing senior secured notes and holdco PIK financing and in the subsequent sale of Limacorporate to Enovis.
• The EQT-led consortium on financing for the £4.5 billion recommended cash offer of Dechra Pharmaceuticals PLC.
• Nordic Capital on its acquisition of ADVANZ Pharma, as well as subsequent acquisition financings by ADVANZ Pharma.
• Hellman & Friedman on acquiring Verisure and subsequent financings totaling over €8 billion (equivalent).
• A consortium led by EQT Partners (EQT) in connection with its acquisition of Cerba and Cerba’s subsequent acquisition of Lifebrain.
• A consortium led by EQT and Abu Dhabi Investment Authority on the cross-border financing for acquiring Nestlé’s Skin Health for CHF10.2 billion.
• CVC Capital Partners on the concurrent exchange offer and private placement with respect to its portfolio company Domestic & General.
• Youngs Seafood, a European food producer, on its debt restructuring and sale.
• Victoria PLC on multiple issuances of senior secured notes, totaling over €1 billion.
• A syndicate of dealer managers in connection with the offer by NewDay to exchange its outstanding senior secured notes due 2024 for new senior secured notes due 2026 and cash consideration.
• The lenders to the consortium of Advent, Cinven, and RAG on bond financing for their acquisition of thyssenkrupp’s Elevator, a leading international provider of elevator technology, with operations in more than 1,000 locations worldwide, headquartered in Germany.
• The initial purchasers on McLaren’s comprehensive refinancing across debt and equity.

Some of the above matters were handled prior to joining Sidley.